Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$25.86 -0.31 | -1.18%
09/26/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 26.17
52 Week High 26.36
52 Week Low 9.51
Avg. Daily Vol. (Mil) 0.58
Beta (3 year) -0.23
Share Related Items
Mkt Cap (Mil) 1,295.64
Shares Out (Mil) 49.51
Float (Mil) 47.44
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.40
Current Ratio 1.70
LT Debt/ Equity 0.04
Total Debt / Equity 0.04
Valuation Ratios
Price Earnings 55.70
Price/Sales 7.41
Price/Book 9.19
Price/Cash Flow 46.40
Per Share Data
Earnings 0.47
Sales 3.53
Book Value 2.85
Cash Flow 0.56
Business Summary
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.
General Information
1550 East Gude Drive
Rockville, MD 20850
www.supernus.com
Industry : Drugs
Sector: Health Care
Employees: 344
CEO: Jack Khattar
Short Interest
Current Month (Mil) 2.37
Previous Month (Mil) 2.57
Short Interest Ratio (Days) 4.70
Management Effectiveness
Return on Equity 18.50
Return on Assets 11.90
Return on Investments 17.80
Profitability
Gross Margin 95.40
EBIT Margin 16.10
Profit Margin 14.90

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter